Thursday, October 24, 2019
8:00 a.m. - 5:00 p.m.

Artificial Intelligence in Oncology Symposium: Advancement and Policy | Oct. 24, 2019

The inaugural Artificial Intelligence in Oncology Symposium will bring together experts in AI and machine learning as well as clinical, industry and federal agency experts in pathology, radiology, oncology and immuno-oncology to speak on research developments, regulatory policy, reimbursement and ethics surrounding AI.

The symposium will feature a number of focused panel discussions and international scientists providing unique perspectives on how analytics can impact the major areas of radiology, pathology and -omics in the contexts of precision medicine approaches for characterizing tumors and predicting therapeutic response.

Beyond the science, attendees will be able to network, explore potential new partnerships and visit exhibitors throughout the day.

AGENDA

8:00-8:45am Breakfast and Registration
8:45-9:05 Welcome and Introduction

Barbara Snyder
President, Case Western Reserve University

Pamela Davis, MD, PhD
Dean, School of Medicine
Case Western Reserve University

Anant Madabhushi, PhD, FAIMBE, FIEEE, FCoulter
Director, Center for Computational Imaging & Personalized Diagnostics
Case Western Reserve University
9:05-10:30 SESSION I – AI in Radiology
Moderator: Pallavi Tiwari, PhD

“Artificial Intelligence in Cancer Imaging”
Hugo Aerts, PhD
Dana-Farber Harvard Cancer Institute

“Characterizing Textural Patterns of Solid Lesions with Bayesian Spatial Modeling”
Brian Hobbs, PhD
Cleveland Clinic, Case Comprehensive Cancer Center

Panel discussion
Session speakers joined by:

Donna Plecha, MD
University Hospitals, Case Western Reserve University

Satish Viswanath, PhD
Case Western Reserve University
10:30-10:45 Break
10:45-12:10pm SESSION II – AI in Pathology & Genomics
Moderator: Vinay Varadan, PhD

“Whole Slide Imaging meets Machine Learning: A Clinician’s Perspective”
Michael Feldman MD, PhD
University of Pennsylvania

“Tempus: Building an operating system for precision oncology”
Kevin White, PhD
Tempus

Panel discussion
Session speakers joined by:

Jill Barnholtz-Sloan, PhD
Case Western Reserve University

Hannah Gilmore, MD
University Hospitals, Case Western Reserve University
12:10-12:30pm Retrieve Lunch
12:30-1:30 Keynote

“Co-evolution of Malignant and Immune Cells in High Grade Serous Ovarian Cancer”

Sohrab P. Shah, PhD
Memorial Sloan Kettering Cancer Center
1:30-2:55 SESSION III – AI in Immuno-Oncology
Moderator: Anant Madabhushi, PhD

“Radiomics and Pathomics in Immuno-oncology”
Anant Madabhushi, PhD
Case Western Reserve University

“Image-based AI Applications in Immuno-Oncology Exploratory Research and Drug Development”
Michael Montalto, PhD
Bristol-Myers Squibb

Panel discussion
Session speakers joined by:

Brian Hobbs, PhD
Cleveland Clinic, Case Western Reserve University

Rong Xu, PhD
Case Western Reserve University

Smitha Krishnamurthi, MD
Cleveland Clinic, Case Western Reserve University
2:55-3:10 Break
3:10-4:35 SESSION IV – Policy & Ethical Considerations for AI
Moderator: Aziz Nazha, MD

“Evaluating AI at the FDA and Related Research”
Brandon Gallas, PhD
US Food and Drug Administration

“Ethics Concerns in Widely Deploying AI in Healthcare”
Sharona Hoffman, JD, LLM, SJD
Case Western Reserve University

Panel discussion
Session speakers joined by:

Dana Crawford, PhD
Case Western Reserve University

Monica Webb Hooper, PhD
Case Western Reserve University
4:35-4:55 Wrap-up and Closing Comments
Register

Where:

Tinkham Veale University Center | 11038 Bellflower Road | Cleveland, Ohio 44106

Contact:

Mary Wright, Assistant Director of Programming Operations
Case Western Reserve University, Case Comprehensive Cancer Center
maw143@case.edu